<DOC>
	<DOCNO>NCT00473655</DOCNO>
	<brief_summary>The primary purpose trial determine treatment rosuvastatin 10 20mg/day 8 week hypertriglyceridemic patient reduce triglyceride level .</brief_summary>
	<brief_title>Effect Rosuvastatin Triglyceride Levels Mexican Hypertriglyceridemic Patients</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Hyperlipoproteinemias</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type IV</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type V</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Patients older 18 year , gender , without previous treatment statin lipid lower drug least 6 month With elevated triglyceride 200 800mg/dl willing follow study procedure include assist clinic , fast blood sample sign write consent High level lowdensity lipoprotein cholesterol ( LDLC ) Unstable cardiovascular condition await myocardial revascularization Congestive cardiac failure Uncontrolled diabetes Cancer Uncontrolled hypothyroidism Familial hypercholesterolemia Liver/muscle disease Pregnancy Other</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Triglycerides</keyword>
	<keyword>hypertriglyceridemia</keyword>
	<keyword>statin</keyword>
	<keyword>rosuvastatin</keyword>
	<keyword>hyperlipoproteinemia</keyword>
	<keyword>Fredrickson Type IIb IV</keyword>
</DOC>